A cross-sectional study of cutaneous immune-related adverse effects in Hispanic patients after immune checkpoint inhibitor use for cancer therapy

J Am Acad Dermatol. 2025 Jan;92(1):168-170. doi: 10.1016/j.jaad.2024.09.030. Epub 2024 Sep 26.

Authors

Katerina Yale¹, Jennifer Roux², Jessica Shiu³

Affiliations

¹ Department of Dermatology, University of California, Irvine, Irvine, California.
² University of California, Irvine, School of Medicine, Irvine, California.
³ Department of Dermatology, University of California, Irvine, Irvine, California. Electronic address: [email protected].

PMID: 39341356
DOI: 10.1016/j.jaad.2024.09.030

No abstract available

Keywords: Hispanic; drug reaction; ethnicity; immune checkpoint inhibitors; immunotherapy; medical dermatology; oncology.